BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11523565)

  • 1. Genetic susceptibility to MS: a second stage analysis in Canadian MS families.
    Dyment DA; Willer CJ; Scott B; Armstrong H; Ligers A; Hillert J; Paty DW; Hashimoto S; Devonshire V; Hooge J; Kastrukoff L; Oger J; Metz L; Warren S; Hader W; Power C; Auty A; Nath A; Nelson R; Freedman M; Brunet D; Paulseth JE; Rice G; O'Connor P; Duquette P; Lapierre Y; Francis G; Bouchard JP; Murray TJ; Bhan V; Maxner C; Pryse-Phillips W; Stefanelli M; Sadovnick AD; Risch N; Ebers GC
    Neurogenetics; 2001 Jul; 3(3):145-51. PubMed ID: 11523565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An extended genome scan in 442 Canadian multiple sclerosis-affected sibships: a report from the Canadian Collaborative Study Group.
    Dyment DA; Sadovnick AD; Willer CJ; Armstrong H; Cader ZM; Wiltshire S; Kalman B; Risch N; Ebers GC;
    Hum Mol Genet; 2004 May; 13(10):1005-15. PubMed ID: 15069025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis.
    Ligers A; Dyment DA; Willer CJ; Sadovnick AD; Ebers G; Risch N; Hillert J;
    Am J Hum Genet; 2001 Oct; 69(4):900-3. PubMed ID: 11519010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel.
    Karni A; Kohn Y; Safirman C; Abramsky O; Barcellos L; Oksenberg JR; Kahana E; Karussis D; Chapman J; Brautbar C
    Mult Scler; 1999 Dec; 5(6):410-5. PubMed ID: 10618697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for linkage disequilibrium between HLA-DRB1 gene and multiple sclerosis. The French Research Group on Genetic Susceptibility to MS.
    Yaouanq J; Semana G; Eichenbaum S; Quelvennec E; Roth MP; Clanet M; Edan G; Clerget-Darpoux F
    Science; 1997 May; 276(5313):664-5. PubMed ID: 9157540
    [No Abstract]   [Full Text] [Related]  

  • 6. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia.
    Marrosu MG; Murru R; Murru MR; Costa G; Zavattari P; Whalen M; Cocco E; Mancosu C; Schirru L; Solla E; Fadda E; Melis C; Porru I; Rolesu M; Cucca F
    Hum Mol Genet; 2001 Dec; 10(25):2907-16. PubMed ID: 11741834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population.
    Marrosu MG; Murru MR; Costa G; Murru R; Muntoni F; Cucca F
    Hum Mol Genet; 1998 Aug; 7(8):1235-7. PubMed ID: 9668164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genome-wide scan in forty large pedigrees with multiple sclerosis.
    Willer CJ; Dyment DA; Cherny S; Ramagopalan SV; Herrera BM; Morrison KME; Sadovnick AD; Risch NJ; Ebers GC
    J Hum Genet; 2007; 52(12):955-962. PubMed ID: 18000641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetics of multiple sclerosis. A review.
    Kalman B; Lublin FD
    Biomed Pharmacother; 1999 Sep; 53(8):358-70. PubMed ID: 10554670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of linkage between susceptibility to multiple sclerosis and HLA-class II loci in Italian multiplex families.
    Eoli M; Pandolfo M; Amoroso A; Salmaggi A; Zaffaroni M; Gasparini P; DiDonato S; Milanese C; Zeviani M
    Eur J Hum Genet; 1995; 3(5):303-11. PubMed ID: 8556305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genome scan in a single pedigree with a high prevalence of multiple sclerosis.
    Dyment DA; Cader MZ; Herrera BM; Ramagopalan SV; Orton SM; Chao M; Willer CJ; Sadovnick AD; Risch N; Ebers GC
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):158-62. PubMed ID: 17550985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine mapping of the multiple sclerosis susceptibility locus on 5p14-p12.
    Riise Stensland HM; Saarela J; Bronnikov DO; Parkkonen M; Jokiaho AJ; Palotie A; Tienari PJ; Sumelahti ML; Elovaara I; Koivisto K; Pirttilä T; Reunanen M; Sobel E; Peltonen L
    J Neuroimmunol; 2005 Dec; 170(1-2):122-33. PubMed ID: 16169605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A first stage genome-wide screen for regions shared identical-by-descent in Hutterite families with multiple sclerosis.
    Dyment DA; Cader MZ; Datta A; Broxholme SJ; Cherny SS; Willer CJ; Ramagopalan S; Herrera BM; Orton S; Chao M; Sadovnick AD; Hader M; Hader W; Ebers GC
    Am J Med Genet B Neuropsychiatr Genet; 2008 Jun; 147B(4):467-72. PubMed ID: 18081025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome 7q21-22 and multiple sclerosis: evidence for a genetic susceptibility effect in vicinity to the protachykinin-1 gene.
    Vandenbroeck K; Fiten P; Heggarty S; Goris A; Cocco E; Hawkins SA; Graham CA; Marrosu MG; Opdenakker G
    J Neuroimmunol; 2002 Apr; 125(1-2):141-8. PubMed ID: 11960650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.
    Chao MJ; Barnardo MC; Lui GZ; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2007 Aug; 16(16):1951-8. PubMed ID: 17584771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis.
    Brynedal B; Duvefelt K; Jonasdottir G; Roos IM; Akesson E; Palmgren J; Hillert J
    PLoS One; 2007 Jul; 2(7):e664. PubMed ID: 17653284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA class II associated risk and protection against multiple sclerosis-a Finnish family study.
    Laaksonen M; Pastinen T; Sjöroos M; Kuokkanen S; Ruutiainen J; Sumelahti ML; Reijonen H; Salonen R; Wikström J; Panelius M; Partanen J; Tienari PJ; Ilonen J
    J Neuroimmunol; 2002 Jan; 122(1-2):140-5. PubMed ID: 11777553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA typing in the United Kingdom multiple sclerosis genome screen.
    Coraddu F; Sawcer S; Feakes R; Chataway J; Broadley S; Jones HB; Clayton D; Gray J; Smith S; Taylor C; Goodfellow PN; Compston A
    Neurogenetics; 1998 Dec; 2(1):24-33. PubMed ID: 9933297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex.
    Chao MJ; Ramagopalan SV; Herrera BM; Lincoln MR; Dyment DA; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2009 Jan; 18(2):261-6. PubMed ID: 19098025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines in genetic susceptibility to multiple sclerosis: a candidate gene approach. French Multiple Sclerosis Genetics Group.
    Reboul J; Mertens C; Levillayer F; Eichenbaum-Voline S; Vilkoren T; Cournu I; Babron MC; Lyon-Caen O; Clerget-Darpoux F; Edan G; Clanet M; Brahic M; Bureau JF; Fontaine B; Liblau R
    J Neuroimmunol; 2000 Jan; 102(1):107-12. PubMed ID: 10626674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.